14-74299649-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005050.4(ABCD4):​c.184T>C​(p.Leu62Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 1,612,364 control chromosomes in the GnomAD database, including 100,730 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7521 hom., cov: 32)
Exomes 𝑓: 0.35 ( 93209 hom. )

Consequence

ABCD4
NM_005050.4 synonymous

Scores

1
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.135

Publications

28 publications found
Variant links:
Genes affected
ABCD4 (HGNC:68): (ATP binding cassette subfamily D member 4) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. The function of this peroxisomal membrane protein is unknown. However, it is speculated that it may function as a heterodimer for another peroxisomal ABC transporter and, therefore, may modify the adrenoleukodystrophy phenotype. It may also play a role in the process of peroxisome biogenesis. Alternative splicing results in several protein-coding and non-protein-coding variants. [provided by RefSeq, Jul 2017]
ABCD4 Gene-Disease associations (from GenCC):
  • methylmalonic acidemia with homocystinuria, type cblJ
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 14-74299649-A-G is Benign according to our data. Variant chr14-74299649-A-G is described in ClinVar as Benign. ClinVar VariationId is 259620.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.135 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCD4NM_005050.4 linkc.184T>C p.Leu62Leu synonymous_variant Exon 3 of 19 ENST00000356924.9 NP_005041.1 O14678A0A024R6B9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCD4ENST00000356924.9 linkc.184T>C p.Leu62Leu synonymous_variant Exon 3 of 19 1 NM_005050.4 ENSP00000349396.4 O14678

Frequencies

GnomAD3 genomes
AF:
0.302
AC:
45911
AN:
151998
Hom.:
7530
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.168
Gnomad AMI
AF:
0.470
Gnomad AMR
AF:
0.303
Gnomad ASJ
AF:
0.443
Gnomad EAS
AF:
0.253
Gnomad SAS
AF:
0.361
Gnomad FIN
AF:
0.311
Gnomad MID
AF:
0.557
Gnomad NFE
AF:
0.369
Gnomad OTH
AF:
0.358
GnomAD2 exomes
AF:
0.325
AC:
81073
AN:
249452
AF XY:
0.338
show subpopulations
Gnomad AFR exome
AF:
0.161
Gnomad AMR exome
AF:
0.223
Gnomad ASJ exome
AF:
0.437
Gnomad EAS exome
AF:
0.242
Gnomad FIN exome
AF:
0.311
Gnomad NFE exome
AF:
0.372
Gnomad OTH exome
AF:
0.373
GnomAD4 exome
AF:
0.352
AC:
514010
AN:
1460248
Hom.:
93209
Cov.:
34
AF XY:
0.355
AC XY:
258047
AN XY:
726364
show subpopulations
African (AFR)
AF:
0.161
AC:
5373
AN:
33460
American (AMR)
AF:
0.230
AC:
10253
AN:
44522
Ashkenazi Jewish (ASJ)
AF:
0.444
AC:
11583
AN:
26094
East Asian (EAS)
AF:
0.242
AC:
9592
AN:
39662
South Asian (SAS)
AF:
0.371
AC:
31972
AN:
86156
European-Finnish (FIN)
AF:
0.314
AC:
16759
AN:
53344
Middle Eastern (MID)
AF:
0.522
AC:
3006
AN:
5760
European-Non Finnish (NFE)
AF:
0.364
AC:
403869
AN:
1110936
Other (OTH)
AF:
0.358
AC:
21603
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
15441
30881
46322
61762
77203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12576
25152
37728
50304
62880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.302
AC:
45903
AN:
152116
Hom.:
7521
Cov.:
32
AF XY:
0.300
AC XY:
22290
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.168
AC:
6978
AN:
41512
American (AMR)
AF:
0.302
AC:
4609
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.443
AC:
1536
AN:
3468
East Asian (EAS)
AF:
0.253
AC:
1307
AN:
5176
South Asian (SAS)
AF:
0.359
AC:
1732
AN:
4818
European-Finnish (FIN)
AF:
0.311
AC:
3293
AN:
10596
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.369
AC:
25099
AN:
67974
Other (OTH)
AF:
0.359
AC:
756
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1611
3222
4832
6443
8054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
17682
Bravo
AF:
0.293
Asia WGS
AF:
0.308
AC:
1069
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Methylmalonic acidemia with homocystinuria, type cblJ Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_noAF
Benign
-0.59
CADD
Benign
6.4
DANN
Benign
0.88
PhyloP100
-0.14
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2301345; hg19: chr14-74766352; COSMIC: COSV53992812; COSMIC: COSV53992812; API